This article is included in these additional categories: Contracts - Awards | Domestic Security | Legal | Medical | Other Corporation | USA
$5.25M for Anti-Flu Inhaler Packages
For more on this and other stories, please consider purchasing a membership.
If you are already a subscriber, login to your account.
If you are already a subscriber, login to your account.
Zanamivir/ Relenza GlaxoSmithKline (GSK) in Philadelphia, PA received a maximum $5.25 million firm fixed price requirements contract for Zanamivir inhalation (Relenza) packages for the US Army, Navy, Air Force, and Marine Corps. There were 2 proposals solicited and 2 responded. Date of performance completion is March 31, 2007. The contract was issued by the Defense […]
One Source: Hundreds of programs; Thousands of links, photos, and analyses
DII brings a complete collection of articles with original reporting and research, and expert analyses of events to your desktop – no need for multiple modules, or complex subscriptions. All supporting documents, links, & appendices accompany each article.
Benefits
- Save time
- Eliminate your blind spots
- Get the big picture, quickly
- Keep up with the important facts
- Stay on top of your projects or your competitors
Features
- Coverage of procurement and doctrine issues
- Timeline of past and future program events
- Comprehensive links to other useful resources
Monthly
$59.95/Per Month
- Charged Monthly
- 1 User
Quarterly
$50/Per Month
- $150 Charged Each Quarter
- 1 User
Yearly
$45/Per Month
- $540 charged each year
- 1 User
2 years
$35/Per Month
- $840 Charged every other year
- 1 User